Skip to main content
Log in

Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Rho-associated protein kinase (ROCK), a molecular switch, modulates cellular functions in many cancers, such as hepatocellular, breast, colon cancers, etc. However, little is known the effect of ROCK on cell adhesion and mobility in esophageal squamous cell cancer (ESCC), one of the most diagnosed cancers in China. In this study, Y-27632 was used to specifically block ROCK activity in ESCC cells. Adhesion of ESCC cells was detected by homotypic and heterotypic adhesion assay together with examination of E-cadherin expression. Motility of ESCC cells changes were examined by detection of phosphorylated cofilin and observed under confocal microscopy, respectively. We found that Y-27632 increased both heterotypic and homotypic adhesion, and the expression of E-cadherin; decreased phosphorylated cofilin resulting in actin rearrangement in ESCC cells. All these findings indicate that ROCK signaling pathway plays an important role in cell adhesion and mobility, suggesting that it may be used as a potential target for therapy of ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ortíz-López L, Morales-Mulia S, Ramírez-Rodríguez G, Benítez-King G (2009) ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 46:15–21

    Article  PubMed  CAS  Google Scholar 

  2. Leve F, de Souza W, Morgado-Díaz JA (2008) A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell–cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 327:777–788

    Article  PubMed  CAS  Google Scholar 

  3. Lawler K, Foran E, O’Sullivan G, Long A, Kenny D (2006) Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 291:C668–C677

    Article  PubMed  CAS  Google Scholar 

  4. Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K (2005) Intrathecal administration of Y-27632, a specific Rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res 3:425–433

    Article  PubMed  Google Scholar 

  5. Shimada T, Nishimura Y, Nishiuma T, Rikitake Y, Hirase T, Yokoyama M (2007) Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 53:125–134

    PubMed  CAS  Google Scholar 

  6. Rösel D, Brábek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanová K, Kollmannsberger P, Panková D, Vesely P, Folk P, Fabry B (2008) Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 6:1410–1420

    Article  PubMed  CAS  Google Scholar 

  7. Xue F, Takahara T, Yata Y, Xia Q, Nonome K, Shinno E, Kanayama M, Takahara S, Sugiyama T (2008) Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res 38:810–817

    Article  PubMed  CAS  Google Scholar 

  8. Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC (2007) ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87:1149–1158

    Article  PubMed  CAS  Google Scholar 

  9. Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG (2008) The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 33:585–593

    PubMed  CAS  Google Scholar 

  10. Papadopoulou N, Charalampopoulos I, Alevizopoulos K, Gravanis A, Stournaras C (2008) Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 314:3162–3174

    Article  PubMed  CAS  Google Scholar 

  11. Ordóñez-Morán P, Larriba MJ, Pálmer HG, Valero RA, Barbáchano A, Duñach M, de Herreros AG, Villalobos C, Berciano MT, Lafarga M, Muñoz A (2008) RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 183:697–710

    Article  PubMed  CAS  Google Scholar 

  12. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE (2008) Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci USA 105:11305–11310

    Article  PubMed  Google Scholar 

  13. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC (2005) p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218:69–79

    Article  PubMed  CAS  Google Scholar 

  14. Whibley CE, Keyzers RA, Soper AG, Davies-Coleman MT, Samaai T, Hendricks DT (2005) Antiesophageal cancer activity from Southern African marine organisms. Ann N Y Acad Sci 1056:405–412

    Article  PubMed  CAS  Google Scholar 

  15. Montesano R, Hollstein M, Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69:225–235

    Article  PubMed  CAS  Google Scholar 

  16. Yoshii A, Iizuka K, Dobashi K, Horie T, Harada T, Nakazawa T, Mori M (1999) Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 20:1190–1200

    PubMed  CAS  Google Scholar 

  17. Tian F, Zang WD, Hou WH, Liu HT, Xue LX (2006) Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 38:318–326

    Article  PubMed  CAS  Google Scholar 

  18. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  PubMed  CAS  Google Scholar 

  19. Hou GQ, Xue LX, Lu ZM, Fan TL, Tian F, Xue YL (2007) An activated mTOR/p70S6 K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 253:236–248

    Article  PubMed  CAS  Google Scholar 

  20. Wang SM, Zhu J, Pan LF, Liu YK (2008) Inhibitory effect of dimeric β peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice. World J Gastroenterol 14:3054–3058

    Article  PubMed  CAS  Google Scholar 

  21. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM (2008) Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 31:1802–1805

    Article  PubMed  CAS  Google Scholar 

  22. Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G, Knaus P (2006) p38 inhibitors prevent TGF-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 47:1500–1509

    Article  PubMed  Google Scholar 

  23. Li Q, Mattingly RR (2008) Restoration of E-cadherin cell–cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 10:1444–1458

    PubMed  CAS  Google Scholar 

  24. Muise AM, Walters TD, Glowacka WK, Griffiths AM, Ngan BY, Lan H, Xu W, Silverberg M, Rotin D (2009) Polymorphisms in E-cadherin (CDH1) result in a mis-localized cytoplasmic protein that is associated with Crohn’s Disease. Gut 58:1121–1127

    Google Scholar 

  25. Molina-Ortiz I, Bartolomé RA, Hernández-Varas P, Colo GP, Teixidó J (2009) Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA. J Biol Chem 284:15147–15157

    Article  PubMed  CAS  Google Scholar 

  26. Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF (2008) Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 52:560–568

    Article  PubMed  Google Scholar 

  27. Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU (2007) Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 35:1–9

    PubMed  Google Scholar 

  28. Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY (2008) Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 14:5665–5673

    Article  PubMed  CAS  Google Scholar 

  29. Filenius S, Tervo T, Virtanen I (2003) Production of fibronectin and tenascin isoforms and their role in the adhesion of human immortalized corneal epithelial cells. Invest Ophthalmol Vis Sci 44:3317–3325

    Article  PubMed  Google Scholar 

  30. Imamura F, Mukai M, Ayaki M, Akedo H (2000) Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res 91:811–816

    PubMed  CAS  Google Scholar 

  31. Han S, Ritzenthaler JD, Sitaraman SV, Roman J (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281:29614–29624

    Article  PubMed  CAS  Google Scholar 

  32. Gill KS, Beier F, Goldberg HA (2008) Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein. Am J Physiol Cell Physiol 295:C38–C49

    Article  PubMed  CAS  Google Scholar 

  33. Honjo M, Tanihara H, Kameda T, Kawaji T, Yoshimura N, Araie M (2007) Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest Ophthalmol Vis Sci 48:5549–5557

    Article  PubMed  Google Scholar 

  34. Jiang P, Enomoto A, Takahashi M (2009) Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. doi:10.1016/j.canlet.2009.02.034

  35. Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS (2005) Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 15:138–145

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the grants from Key Programs of Science and Technology of Education Ministry of China (No. 00190) and the Tenth Five-Year Plan’s “211 Projects “of Education Ministry of China (No. 2002-2).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lexun Xue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Xue, L., Yan, H. et al. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep 37, 1971–1977 (2010). https://doi.org/10.1007/s11033-009-9645-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9645-9

Keywords

Navigation